Efficacy and safety of cladribine addition to induction treatment of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis.

Abstract:

OBJECTIVES:Compared with the 3 + 7 regimen, the cladribine-containing regimen has led to improvements in the rate of complete remission (CR) in the treatment of newly diagnosed acute myeloid leukemia (AML) patients. We conducted a systematic review and meta-analysis to investigate the overall efficacy and safety of cladribine-containing regimens in the induction treatment of newly diagnosed AML patients. METHODS:Eligible studies were identified from the PubMed, EMBASE, and Cochrane Library databases. Efficacy was assessed by CR rate, disease-free survival (DFS), and overall survival (OS). Safety was evaluated based on the early death (ED) rate, days for neutrophils<0.5 × 109/L, days for platelets<50 × 109/L, and duration of hospital stay after treatment. RESULTS:A total of 14 clinical trials were included in this meta-analysis, enrolling a total of 1058 newly diagnosed AML patients. The pooled estimate with a 95% confidence interval (CI) for CR was 64% (95% CI: 58-70%). Compared with the control group, the CR rate of the cladribine-containing regimen was higher (OR was 1.92 (95% CI: 1.55-2.38)). The combined ED rate was estimated to be 10% (95% CI: 5-14%). Compared with the control group, the ED rate of the cladribine-containing regimen was not increased (OR was 1.09 (95% CI: 0.78-1.53)). CONCLUSION:This meta-analysis suggests that cladribine-containing regimens are likely to be effective and safe for induction treatment of newly diagnosed AML patients. However, large sample size and prospective controlled studies are needed to confirm our findings.

journal_name

Hematology

authors

Pan Q,Li J

doi

10.1080/16078454.2021.1962047

keywords:

["Cladribine","acute myeloid leukemia","induction treatment","meta-analysis"]

subject

Has Abstract

pub_date

2021-12-01 00:00:00

pages

577-587

issue

1

eissn

1024-5332

issn

1607-8454

journal_volume

26

pub_type

杂志文章

相关文献

文献大全
  • Malignancy: Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alpha.

    abstract::Telomeres consist of simple tandem hexametric (TTAGGG) repeats and progressively shorten with cell replication. To determine a relationship between telomeric erosion and response to treatment, we measured telomere length following treatment in patients with chronic myeloid leukemia (CML) in the chronic phase. We used ...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.1999.11746425

    authors: Hayashi S,Iwama H,Yahata N,Ando K,Ohyashiki JH,Ohyashiki K

    更新日期:1999-01-01 00:00:00

  • Molecular Medicine and Molecular Pathology for Hematologists: II. Lets go Techno; Principles of the Molecular Technologies and their Applications in Haematology.

    abstract::Molecular techniques have a key role to play in laboratory and clinical haematology. Restriction enzymes allow nucleic acids to be reduced in size for subsequent analysis. In addition they allow selection of specific DNA or RNA sequences for cloning into bacterial plasmids. These plasmids are naturally occuring DNA mo...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.1999.11746438

    authors: Lawler M

    更新日期:1999-01-01 00:00:00

  • Haemostasis and Thrombosis: Current Clinical Practice: Low-Molecular-Weight Heparins in The Prophylaxis and Treatment of Thrombo-Embolic Disease.

    abstract::Low-Molecular-Weight Heparin (LMWH) fractions are prepared from standard unfractionated heparin (UFH) and are thus similar to it in many aspects. The major advantages of LMWH are improved efficacy and safety, longer half-life and reduced need for laboratory monitoring. In addition, the dangers of UFH administered by c...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:

    authors: O'Shaughnessy DF

    更新日期:2000-01-01 00:00:00

  • Malignancy: Idiotypic Immune Targeting of Multiple Myeloma.

    abstract::Immunotherapy of malignant diseases remains a major therapeutic challenge. In multiple myeloma, interests have been focussed primarily on the targeting of the idiotypic protein since it represents one of the few tumor specific antigens. Various vaccination strategies have been employed, including the use of naked prot...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:

    authors: Lim SH,Wen YJ,Ling M

    更新日期:2000-01-01 00:00:00

  • Malignancy: Myeloma - the Elusive Cure.

    abstract::Myeloma accounts for 1% of all malignancies and is characterised by the malignant expansion of plasma cells. It is essentially incurable with a median survival of 6 months untreated. Typically disseminated at presentation, myeloma requires systemic therapy, in those patients with advanced or progressive disease. Of si...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.2000.11746485

    authors: Smith ML,Kelsey SM

    更新日期:2000-01-01 00:00:00

  • Hematopoiesis: Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hemopoietic Stem Cells.

    abstract::The 80-100 fold increased immunohistological expression of the Gap Junction (GJ) protein Connexin-43 in murine bone marrow during the neonatal period and directly following cytoreductive treatment of adult mice suggests that the regulation of stem cell proliferation may involve GJ Intercellular Communication (GJIC). U...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.2000.11746498

    authors: Ploemacher RE,Mayen AE,De Koning AE,Krenacs T,Rosendaal M

    更新日期:2000-01-01 00:00:00

  • Sequential Variations in the Content of Bone Marrow Colony-forming Cells in Individual Patients with Aplastic Anemia Before and After Immunosuppressive Therapy; Hematopoiesis.

    abstract::Previous studies have shown that the levels of hematopoietic progenitor cells (colony-forming cells; CFC) are drastically reduced in the vast majority of patients with aplastic anemia (AA). This has been observed both in patients before and after immunosuppressive therapy. In those studies, however, both groups of pat...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.2000.11746513

    authors: Martínez-Jaramillo G,Sánchez-Valle E,Gómez-Morales E,Montesinos JJ,Valencia I,Pizzuto-Chavez J,Mayani H

    更新日期:2000-01-01 00:00:00

  • Involvement of E-cadherin in the Development of Erythroid Cells; Subject Heading.

    abstract::The cadherins represent a large family of structurally and functionally related cell adhesion molecules involved in morphogenesis of multicellular organisms and maintenance of solid tissues. In the hematopoietic system, however, almost nothing was known about the involvement of this family. PCR screening of RNA of hum...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245332.2000.11746524

    authors: Armeanu S,MÜller CA,Klein G

    更新日期:2000-01-01 00:00:00

  • Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective; Subject Heading.

    abstract::Little is known about the hematopoietic stem and progenitor cell membrane recognition and adhesion molecules which mediate their specific patterns of movement into and out of the marrow compartment during steady state hematopoiesis and during pathological conditions. Implicit in the cellular targeting of these cells t...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:

    authors: Hardy CL

    更新日期:2001-01-01 00:00:00

  • Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia.

    abstract::An 8-month-old girl had acute myelogenous leukemia (EAB M2) that relapsed 5 months after diagnosis during intensive consolidation chemotherapy. She underwent bone marrow transplantation (BMT) from an HLA-A, -B, -C and -DR phenotypically matched, but one locus DRB1 genotypically mismatched unrelated donor, but rejectio...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330290022142

    authors: Shibuya A,Kaneko I,Ishii S,Sasaki N

    更新日期:2002-04-01 00:00:00

  • Peyronie's disease as a complication of chronic graft versus host disease.

    abstract::Apart from one report of phimosis, involvement of the penis has not been reported as a complication of chronic GVHD. We report a patient with recurrent chronic GVHD who developed skin discoloration of the penile shaft, together with erectile dysfunction consistent with Peyronie's disease. Histological features were co...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/1024533021000008182

    authors: Grigg AP,Underhill C,Russell J,Sale G

    更新日期:2002-06-01 00:00:00

  • Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?

    abstract::The therapeutic options for the indolent non-Hodgkin's lymphomas have evolved significantly over the years. However, at present, allogeneic haematopoietic stem cell transplantation (HSCT), despite its significant transplant associated complications, is still the only option which may be delivered with curative potenti...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/1024533021000047945

    authors: Ho AY,Pagliuca A

    更新日期:2002-12-01 00:00:00

  • Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures.

    abstract::Chronic myeloid leukemia (CML) is a hematological neoplasia that results from the transformation of a hematopoietic stem cell. It is characterized by the expansion of the myeloid lineage, which results in the accumulation of mature and immature granulocytes in peripheral blood and bone marrow. However, when CML marrow...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/1024533031000112248

    authors: Luna-Bautista F,Sánchez-Valle E,Ayala-Sánchez M,Morales-Polanco M,Meillon-García L,Benítez-Bribiesca L,Mayani H

    更新日期:2003-06-01 00:00:00

  • Dendritic cell-based immunotherapy for the treatment of hematological malignancies.

    abstract::Dendritic cells (DCs) are professional antigen-presenting cells and are frequently used in current immunotherapy protocols. The administration of DCs loaded with tumor-associated proteins or peptides results in the induction of immune responses against different types of malignant cells. Methods for large-scale genera...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/1024533031000084204

    authors: Büchler T,Michalek J,Kovarova L,Musilova R,Hajek R

    更新日期:2003-04-01 00:00:00

  • Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors.

    abstract::Syndecan-1 (CD138) mediates myeloma cell adhesion, and loss of syndecan-1 from the cell surface may contribute to myeloma cell proliferation and dissemination and influence the prognosis in patients with multiple myeloma (MM). In order to test this hypothesis, we have evaluated syndecan-1 expression on the surface of ...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/1024533031000153630

    authors: Aref S,Goda T,El-Sherbiny M

    更新日期:2003-08-01 00:00:00

  • The proteasome: a novel therapeutic target in haematopoietic malignancy.

    abstract::The proteasome plays a key role in regulating protein degradation in eukaryotic cells. A range of synthetic inhibitors of proteasome activity have been developed which have helped elucidate its role in the cell. These inhibitors have selectively induced apoptosis in malignant cells in vitro suggesting that the proteas...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/10245330310001604755

    authors: Magill L,Walker B,Irvine AE

    更新日期:2003-10-01 00:00:00

  • Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.

    abstract::These studies were designed as two experiments. Experiment 1 was performed to validate the hypothesis that oxygen saturation of the venous blood may be a marker for vaso-occlusive crisis (VOC) in sickle cell patients undergoing hydroxyurea (HU) treatments. Experiment 2 was performed to test the hypothesis that an acut...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330310001621251

    authors: Nahavandi M,Tavakkoli F,Wyche MQ,Perlin E,Millis RM

    更新日期:2003-12-01 00:00:00

  • Clinico-haematological profile of HbE syndrome in adults and children.

    abstract::Haemoglobin E beta thalassemia (HbE beta thalassemia) has a remarkable variability in clinical expression ranging from a mild form of thalassemia intermedia to a transfusion dependent condition. An overlap between the mild variety of HbE beta thalassemia and homozygous HbE disease is common, however, differentiation i...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330310001638983

    authors: Tyagi S,Pati HP,Choudhry VP,Saxena R

    更新日期:2004-02-01 00:00:00

  • Mu-heavy chain disease associated with systemic amyloidosis.

    abstract::mu-heavy chain disease (HCD) is very rare, with only 30 cases reported in the literature. We report a patient with mu-HCD associated with systemic amyloidosis. The diagnosis of mu-HCD was based on findings of mu-heavy chain fragments in the serum, Bence Jones proteinuria and vacuolated plasma cells in the bone marrow....

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330410001671561

    authors: Kinoshita K,Yamagata T,Nozaki Y,Sugiyama M,Ikoma S,Funauchi M,Kanamaru A

    更新日期:2004-04-01 00:00:00

  • Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment.

    abstract::Therapy-related leukemia and therapy-related myelodysplasia (t-AML/MDS) are serious and increasingly frequent complications of cytotoxic chemotherapy and/or radiotherapy. Two syndromes can be distinguished, one of which has a long latency (5-7 years or more) and is seen following alkylating agents, frequently with an ...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/10245330410001701503

    authors: Rund D,Ben-Yehuda D

    更新日期:2004-06-01 00:00:00

  • Arginine supplementation improves rotorod performance in sickle transgenic mice.

    abstract::Patients with sickle cell disease (SCD) have been shown to have impaired visual-motor speed and coordination. Sensorimotor deficits in mice can be investigated by motor coordination tests that require whole body movements such as the rotorod. A sickle transgenic mouse model (S+S-Antilles) that expresses human alpha, h...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330410001714185

    authors: Fasipe FR,Ubawike AE,Eva R,Fabry ME

    更新日期:2004-08-01 00:00:00

  • Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia.

    abstract::Second malignancies are frequent complications in patients with chronic lymphocytic leukemia (CLL). Patients with this leukemia may develop large cell lymphoma (LCL) known as Richter's syndrome (RS). RS occurs in CLL patients of about 3% and may develop in a single lymph node or more often in a group of nodes. However...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/10245330400018599

    authors: Robak T

    更新日期:2004-10-01 00:00:00

  • Coagulopathy, following medical therapy, for carcinoma of the prostate.

    abstract::Cancer of the prostate can be associated with coagulopathy characterized as primary fibrinolysis or diffuse intravascular coagulopathy (DIC) with secondary fibrinolysis. These complications are usually associated with surgical manipulation of the prostate or with advanced metastatic disease. This report describes a pa...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330410001701594

    authors: Bern MM

    更新日期:2005-02-01 00:00:00

  • Clonal expanded TCR Vbeta T cells in patients with APL.

    abstract::T-cell receptor Vss gene repertoire and clonality have been studied in patients with leukemia and solid tumors, by assaying the CDR3 size of TCR genes, using RT-PCR and genescan analysis. Few studies have studied leukemia-associated oligoclonal expanded T-cells in leukemia, therefore, the aim of this study was to inve...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330400026196

    authors: Li Y,Chen S,Yang L,Zhou Y,Wu X,Huang M,Geng S

    更新日期:2005-04-01 00:00:00

  • Arsenic trioxide: an anti cancer missile with multiple warheads.

    abstract::The proven efficacy of ATO in the treatment of APL and the emerging importance of ATO in other diseases prompted extensive studies of the mechanisms of action of ATO in APL and in other types of cancers. In this review we will focus on downstream events in ATO-induced intrinsic and extrinsic apoptotic pathways with an...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章,评审

    doi:10.1080/10245330500067090

    authors: Gazitt Y,Akay C

    更新日期:2005-06-01 00:00:00

  • Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: a case report and review.

    abstract::The authors report the case of an 80-year-old male patient who presented with colitis and severe thrombocytopenia. The work-up revealed concurrent cytomegalovirus infection. After failure of prednisone, a single infusion of high-dose intravenous immunoglobulin produced a rapid and sustained response. Seventeen cases f...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330500093658

    authors: Alliot C,Barrios M

    更新日期:2005-08-01 00:00:00

  • Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura.

    abstract::In 29 symptomatic children of both sexes with chronic idiopathic thrombocytopenic purpura (CITP) with platelet counts < or = 30,000/mm3, of mean age 7.2 +/- 1.3 years, the side effects of long-term glucocorticoid therapy were evaluated. Patients were divided into three groups based on the different glucocorticoid prot...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330500168740

    authors: Ferrara M,Borrelli B,Greco N,Coppola L,Coppola A,Simeone G,Perrotta A,Capozzi L,Esposito L

    更新日期:2005-10-01 00:00:00

  • Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia.

    abstract:INTRODUCTION:Risk factors for thrombosis (TB) in thrombocythaemia (TC) associated with myeloproliferative disorder (MPD) are not well defined. METHODS:We measured antiphospholipid antibodies (APLA) in 35 patients with TC associated with MPD. Fourteen had TB and 21 did not. We assayed IgG and IgM APLA by ELISA for 6 an...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330500226860

    authors: Bidot CJ,Jy W,Horstman LL,Ahn ER,Bidot L,Fontana V,Ahn YS

    更新日期:2005-12-01 00:00:00

  • Neurofibromatosis type I and smoldering multiple myeloma: a case report.

    abstract::We present a case of a 64-year-old woman with neurofibromatosis (NF1) and smoldering multiple myeloma (SMM). SMM was diagnosed 9 years ago when the asymptomatic patient was found to have mild anemia, IgA paraproteinemia, hypogammaglobulinemia, osteopenia without any lytic bone lesions and bone marrow plasmacytosis. Du...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330500328427

    authors: Danilatou V,Liapi D,Psyllaki M,Chatzivasili A,Chronaki I,Heliakis P

    更新日期:2006-02-01 00:00:00

  • Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation.

    abstract::The pathogenesis of thrombotic microangiopathy (TMA) after allogeneic bone marrow transplantation (BMT) remains unclear since ADAMTS13, which is implicated in primary thrombotic thrombocytopenic purpura (TTP), has been shown to have no role in this condition. We investigated whether the onset of TMA after BMT could be...

    journal_title:Hematology (Amsterdam, Netherlands)

    pub_type: 杂志文章

    doi:10.1080/10245330600574219

    authors: Takatsuka H,Nakajima T,Nomura K,Wakae T,Toda A,Itoi H,Okada M,Misawa M,Hara H

    更新日期:2006-04-01 00:00:00